Omeros lands $6.7M grant to test treatment for cocaine addiction


The Seattle-based biotech says its drug candidate is also aimed at alcohol, nicotine and opioid addiction.

Previous Health care startup Rezilient brings on new investor, Govo, as it pursues growth
Next Amid record shootings of kids, BJC HealthCare to distribute gun locks at 20 more locations